— Know what they know.
Not Investment Advice
Also trades as: VLNS.TO (TSX) · $vol 0M

VLNS NASDAQ

The Valens Company Inc.
1W: +5.8% 1M: -5.9% 3M: +13.4% 1Y: -68.1%
$0.76
Last traded 2023-01-13 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $61.5M mcap
Smart Money Score
No convergence signal
Key Statistics
Market Cap$61.5M
52W Range0.58-3.0
Volume44,625
Avg Volume120,946
Beta0.00
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOJeffrey Fallows CFA
Employees445
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2009-09-28
96 Spadina Avenue
Toronto, ON M5V 2J6
CA
About The Valens Company Inc.

The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products. The company also provides a range of products, including tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, concentrates, topicals, edibles, natural health, and other products. In addition, it offers CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation, product development, and custom manufacturing services. The company was formerly known as Valens Groworks Corp. and changed its name to The Valens Company Inc. in June 2020. The Valens Company Inc. is headquartered in Toronto, Canada.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms